Investors

News & Publications

News Releases

News Releases

August 7, 2019
Arvinas To Present at the Wedbush PacGrow Healthcare Conference
NEW HAVEN, Conn. , Aug. 07, 2019 (GLOBE NEWSWIRE) -- Arvinas Inc. (Nasdaq: ARVN), a biotechnology company creating a new class of drugs based on targeted protein degradation, today announced that the company is scheduled to present at the 2019 Wedbush PacGrow Healthcare Conference on Wednesday,
July 29, 2019
Arvinas Appoints Ronald Peck, M.D. as Chief Medical Officer
NEW HAVEN, Conn. , July 29, 2019 (GLOBE NEWSWIRE) -- Arvinas, Inc. (Nasdaq: ARVN), a biotechnology company creating a new class of drugs based on targeted protein degradation, announced today the appointment of Ronald Peck , M.D. to the newly created position of Chief Medical Officer (CMO). Dr.
June 20, 2019
Arvinas to Present at the BMO Prescriptions for Success Healthcare Conference
NEW HAVEN, Conn. , June 20, 2019 (GLOBE NEWSWIRE) -- Arvinas Inc. (Nasdaq: ARVN), a biotechnology company creating a new class of drugs based on protein degradation, today announced that Ian Taylor , Ph.D., Chief Scientific Officer, will participate in a fireside chat at the BMO Prescriptions for
Displaying 1 - 10 of 19